Literature DB >> 21966562

Involvement of ubiquilin-1 transcript variants in protein degradation and accumulation.

Annakaisa Haapasalo1, Jayashree Viswanathan, Kaisa Ma Kurkinen, Lars Bertram, Hilkka Soininen, Nico P Dantuma, Rudolph E Tanzi, Mikko Hiltunen.   

Abstract

Controlled management of protein levels and quality is essential for normal cellular function. Specific molecular chaperones and foldases monitor the levels and assist correct folding of proteins. The ubiquitin-proteasome system recognizes and degrades misfolded proteins that can otherwise be harmful to cells. However, when misfolded or aggregated proteins excessively accumulate, they may be sequestered to the microtubule-organizing center to form aggresomes. These may then be removed from cells by autophagocytosis. Abnormal protein accumulation and aggregation is a common hallmark of many neurodegenerative diseases. In a recent study, we provide evidence that specific transcript variants (TVs) of ubiquilin-1, which are genetically and functionally associated to Alzheimer's disease (AD), regulate proteasomal and aggresomal targeting of presenilin-1 (PS1), a key player in AD pathogenesis. Our study together with current data provide interesting implications for ubiquilin-1 and its TVs in the pathogenesis of AD and other neurodegenerative diseases involving abnormal protein aggregation.

Entities:  

Keywords:  aggresome; autophagocytosis; high-molecular-weight; presenilin-1; proteasome; transcript variant

Year:  2011        PMID: 21966562      PMCID: PMC3181512          DOI: 10.4161/cib.4.4.15283

Source DB:  PubMed          Journal:  Commun Integr Biol        ISSN: 1942-0889


  26 in total

Review 1.  Aggresomes, inclusion bodies and protein aggregation.

Authors:  R R Kopito
Journal:  Trends Cell Biol       Date:  2000-12       Impact factor: 20.808

2.  The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome.

Authors:  M F Kleijnen; A H Shih; P Zhou; S Kumar; R E Soccio; N L Kedersha; G Gill; P M Howley
Journal:  Mol Cell       Date:  2000-08       Impact factor: 17.970

3.  Overexpression of ubiquilin decreases ubiquitination and degradation of presenilin proteins.

Authors:  Leann K Massey; Alex L Mah; Diana L Ford; Jaime Miller; Jing Liang; Howard Doong; Mervyn J Monteiro
Journal:  J Alzheimers Dis       Date:  2004-02       Impact factor: 4.472

4.  Ubiquilin 1 modulates amyloid precursor protein trafficking and Abeta secretion.

Authors:  Mikko Hiltunen; Alice Lu; Anne V Thomas; Donna M Romano; Minji Kim; Phill B Jones; Zhongcong Xie; Maria Z Kounnas; Steven L Wagner; Oksana Berezovska; Bradley T Hyman; Giuseppina Tesco; Lars Bertram; Rudolph E Tanzi
Journal:  J Biol Chem       Date:  2006-08-31       Impact factor: 5.157

5.  Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue.

Authors:  M B Podlisny; M Citron; P Amarante; R Sherrington; W Xia; J Zhang; T Diehl; G Levesque; P Fraser; C Haass; E H Koo; P Seubert; P St George-Hyslop; D B Teplow; D J Selkoe
Journal:  Neurobiol Dis       Date:  1997       Impact factor: 5.996

6.  The UBL domain of PLIC-1 regulates aggresome formation.

Authors:  Renu Heir; Celine Ablasou; Emilie Dumontier; Meghan Elliott; Christine Fagotto-Kaufmann; Fiona K Bedford
Journal:  EMBO Rep       Date:  2006-11-03       Impact factor: 8.807

Review 7.  Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases.

Authors:  Dennis J Selkoe
Journal:  Nat Cell Biol       Date:  2004-11       Impact factor: 28.824

8.  Family-based association between Alzheimer's disease and variants in UBQLN1.

Authors:  Lars Bertram; Mikko Hiltunen; Michele Parkinson; Martin Ingelsson; Christoph Lange; Karunya Ramasamy; Kristina Mullin; Rashmi Menon; Andrew J Sampson; Monica Y Hsiao; Kathryn J Elliott; Gonül Velicelebi; Thomas Moscarillo; Bradley T Hyman; Steven L Wagner; K David Becker; Deborah Blacker; Rudolph E Tanzi
Journal:  N Engl J Med       Date:  2005-03-03       Impact factor: 91.245

9.  Role of ubiquilin associated with protein-disulfide isomerase in the endoplasmic reticulum in stress-induced apoptotic cell death.

Authors:  Han Seok Ko; Takashi Uehara; Yasuyuki Nomura
Journal:  J Biol Chem       Date:  2002-07-02       Impact factor: 5.157

10.  Identification of ubiquitin-interacting proteins in purified polyglutamine aggregates.

Authors:  Hiroshi Doi; Kenichi Mitsui; Masaru Kurosawa; Yoko Machida; Yoshiyuki Kuroiwa; Nobuyuki Nukina
Journal:  FEBS Lett       Date:  2004-07-30       Impact factor: 4.124

View more
  4 in total

1.  The STI and UBA Domains of UBQLN1 Are Critical Determinants of Substrate Interaction and Proteostasis.

Authors:  Zimple Kurlawala; Parag P Shah; Charmi Shah; Levi J Beverly
Journal:  J Cell Biochem       Date:  2017-04-25       Impact factor: 4.429

2.  Protein aggregation and degradation mechanisms in neurodegenerative diseases.

Authors:  Mari Takalo; Antero Salminen; Hilkka Soininen; Mikko Hiltunen; Annakaisa Haapasalo
Journal:  Am J Neurodegener Dis       Date:  2013-03-08

3.  Ubiquilin 2 is not associated with tau pathology.

Authors:  Anna Nölle; Elise S van Haastert; Rob Zwart; Jeroen J M Hoozemans; Wiep Scheper
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

Review 4.  The life cycle of the 26S proteasome: from birth, through regulation and function, and onto its death.

Authors:  Ido Livneh; Victoria Cohen-Kaplan; Chen Cohen-Rosenzweig; Noa Avni; Aaron Ciechanover
Journal:  Cell Res       Date:  2016-07-22       Impact factor: 25.617

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.